AAAAAA

   
Results: 1-20 |
Results: 20
VARIABILITY MORPHINE DISPOSITION DURING LONG-TERM SUBCUTANEOUS INFUSION IN TERMINALLY ILL CANCER-PATIENTS
Authors: VERMEIRE A REMON JP ROSSEEL MT BELPAIRE F DEVULDER J BOGAERT MG
Citation: A. Vermeire et al., VARIABILITY MORPHINE DISPOSITION DURING LONG-TERM SUBCUTANEOUS INFUSION IN TERMINALLY ILL CANCER-PATIENTS, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 325-330
CLINICAL-PHARMACOLOGY TEACHING IN BELGIUM AND THE NETHERLANDS
Authors: VANBORTEL LM BOGAERT MG
Citation: Lm. Vanbortel et Mg. Bogaert, CLINICAL-PHARMACOLOGY TEACHING IN BELGIUM AND THE NETHERLANDS, British Journal of Pharmacology, 123, 1998, pp. 372-372
DIRECT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF DIASTEREOMERIC OXPRENOLOL GLUCURONIDES
Authors: LAETHEM ME BELPAIRE FM BOGAERT MG
Citation: Me. Laethem et al., DIRECT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF DIASTEREOMERIC OXPRENOLOL GLUCURONIDES, Journal of chromatography B. Biomedical applications, 675(2), 1996, pp. 251-255
TOPICAL TREATMENTS FOR HEAD LICE - REPLY
Authors: VANDERSTICHELE RH BOGAERT MG DEZEURE E
Citation: Rh. Vanderstichele et al., TOPICAL TREATMENTS FOR HEAD LICE - REPLY, BMJ. British medical journal, 312(7023), 1996, pp. 123-123
ATTITUDE OF PHYSICIANS TOWARD PATIENT PACKAGE INSERTS FOR MEDICATION INFORMATION IN BELGIUM
Authors: VANDERSTICHELE RH DEPOTTER B VYNCKE P BOGAERT MG
Citation: Rh. Vanderstichele et al., ATTITUDE OF PHYSICIANS TOWARD PATIENT PACKAGE INSERTS FOR MEDICATION INFORMATION IN BELGIUM, Patient education and counseling, 28(1), 1996, pp. 5-13
HOW DO CALCIUM-CHANNEL BLOCKERS PREVENT CARDIOVASCULAR EVENTS - ARE THEY ALL ALIKE
Authors: BOGAERT MG
Citation: Mg. Bogaert, HOW DO CALCIUM-CHANNEL BLOCKERS PREVENT CARDIOVASCULAR EVENTS - ARE THEY ALL ALIKE, Drugs, 52, 1996, pp. 3-7
HOW DO CALCIUM-CHANNEL BLOCKERS PREVENT CARDIOVASCULAR EVENTS - ARE THEY ALL ALIKE - DISCUSSION
Authors: LIE KI BOGAERT MG
Citation: Ki. Lie et Mg. Bogaert, HOW DO CALCIUM-CHANNEL BLOCKERS PREVENT CARDIOVASCULAR EVENTS - ARE THEY ALL ALIKE - DISCUSSION, Drugs, 52, 1996, pp. 7-8
UNTITLED
Authors: DESCHAEPDRYVER AF BOGAERT MG LEFEBVRE RA
Citation: Af. Deschaepdryver et al., UNTITLED, Archives internationales de pharmacodynamie et de therapie, 331(3), 1996, pp. 219-219
CYTOCHROME-P450 - GENETIC-POLYMORPHISM AND DRUG-INTERACTIONS
Authors: BELPAIRE FM BOGAERT MG
Citation: Fm. Belpaire et Mg. Bogaert, CYTOCHROME-P450 - GENETIC-POLYMORPHISM AND DRUG-INTERACTIONS, Acta Clinica Belgica, 51(4), 1996, pp. 254-260
CLINICAL EFFICACY OF TREATMENT FOR HEAD LICE - REPLY
Authors: VANDERSTICHELE RH BOGAERT MG
Citation: Rh. Vanderstichele et Mg. Bogaert, CLINICAL EFFICACY OF TREATMENT FOR HEAD LICE - REPLY, BMJ. British medical journal, 311(7016), 1995, pp. 1369-1370
SYSTEMATIC REVIEW OF CLINICAL EFFICACY OF TOPICAL TREATMENTS FOR HEADLICE
Authors: VANDERSTICHELE RH DEZEURE EM BOGAERT MG
Citation: Rh. Vanderstichele et al., SYSTEMATIC REVIEW OF CLINICAL EFFICACY OF TOPICAL TREATMENTS FOR HEADLICE, BMJ. British medical journal, 311(7005), 1995, pp. 604-608
STEREOSELECTIVE PHARMACOKINETICS OF OXPRENOLOL, PROPRANOLOL, AND VERAPAMIL - SPECIES-DIFFERENCES AND INFLUENCE OF ENDOTOXIN
Authors: LAETHEM ME BELPAIRE FM WIJNANT P BOGAERT MG
Citation: Me. Laethem et al., STEREOSELECTIVE PHARMACOKINETICS OF OXPRENOLOL, PROPRANOLOL, AND VERAPAMIL - SPECIES-DIFFERENCES AND INFLUENCE OF ENDOTOXIN, Chirality, 7(8), 1995, pp. 616-622
EFFECT OF PROBENECID ON THE ENANTIOSELECTIVE PHARMACOKINETICS OF OXPRENOLOL AND ITS GLUCURONIDES IN THE RABBIT
Authors: LAETHEM ME BELPAIRE FM WIJNANT P BOGAERT MG
Citation: Me. Laethem et al., EFFECT OF PROBENECID ON THE ENANTIOSELECTIVE PHARMACOKINETICS OF OXPRENOLOL AND ITS GLUCURONIDES IN THE RABBIT, Pharmaceutical research, 12(12), 1995, pp. 1964-1967
PROTEIN-BINDING OF PROPRANOLOL AND VERAPAMIL ENANTIOMERS IN MATERNAL AND FETAL SERUM
Authors: BELPAIRE FM WYNANT P VANTRAPPEN P DHONT M VERSTRAETE A BOGAERT MG
Citation: Fm. Belpaire et al., PROTEIN-BINDING OF PROPRANOLOL AND VERAPAMIL ENANTIOMERS IN MATERNAL AND FETAL SERUM, British journal of clinical pharmacology, 39(2), 1995, pp. 190-193
PEDICULUS HUMANUS CAPITIS IN SCHOOLCHILDREN
Authors: VANDERSTICHELE RH BOGAERT MG
Citation: Rh. Vanderstichele et Mg. Bogaert, PEDICULUS HUMANUS CAPITIS IN SCHOOLCHILDREN, Lancet, 345(8951), 1995, pp. 731-731
STEREOSELECTIVE PHARMACOKINETICS OF OXPRENOLOL AND ITS GLUCURONIDES IN HUMANS
Authors: LAETHEM ME LEFEBVRE RA BELPAIRE FM VANHOE HL BOGAERT MG
Citation: Me. Laethem et al., STEREOSELECTIVE PHARMACOKINETICS OF OXPRENOLOL AND ITS GLUCURONIDES IN HUMANS, Clinical pharmacology and therapeutics, 57(4), 1995, pp. 419-424
CLINICAL PHARMACOKINETICS OF NITRATES
Authors: BOGAERT MG
Citation: Mg. Bogaert, CLINICAL PHARMACOKINETICS OF NITRATES, Cardiovascular drugs and therapy, 8(5), 1994, pp. 693-699
INFLUENCE OF ENDOTOXIN ON THE STEREOSELECTIVE PHARMACOKINETICS OF OXPRENOLOL, PROPRANOLOL, AND VERAPAMIL IN THE RAT
Authors: LAETHEM ME BELPAIRE FM WIJNANT P ROSSEEL MT BOGAERT MG
Citation: Me. Laethem et al., INFLUENCE OF ENDOTOXIN ON THE STEREOSELECTIVE PHARMACOKINETICS OF OXPRENOLOL, PROPRANOLOL, AND VERAPAMIL IN THE RAT, Chirality, 6(5), 1994, pp. 405-410
AGING AND THE PHARMACOKINETICS AND METABOLISM OF METOPROLOL ENANTIOMERS IN THE RAT
Authors: VERMEULEN AM BELPAIRE FM DESMET F VERCRUYSSE I BOGAERT MG
Citation: Am. Vermeulen et al., AGING AND THE PHARMACOKINETICS AND METABOLISM OF METOPROLOL ENANTIOMERS IN THE RAT, Journal of gerontology, 48(3), 1993, pp. 108-114
THE INFLUENCE OF AGING ON THE STEREOSELECTIVE PHARMACOKINETICS OF PROPRANOLOL IN THE RAT
Authors: VERMEULEN AM BELPAIRE FM MOERMAN E DESMET F BOGAERT MG
Citation: Am. Vermeulen et al., THE INFLUENCE OF AGING ON THE STEREOSELECTIVE PHARMACOKINETICS OF PROPRANOLOL IN THE RAT, Chirality, 4(2), 1992, pp. 73-79
Risultati: 1-20 |